Principal Engineer In The Image Guided Therapy Devices Division
Philips bought Spectranetics in July, 2017. Supported the US market launch of Stellarex with published technical rationale for the outstanding clinical performance of this Drug Coated Balloon, especially in calcified lesions. Established stability program and technical know how for Stellarex products.. Led the design and execution of chemical degradation.